5 Best Wide Moat Stocks to Buy According to Wall Street Analysts

3. Zoetis Inc. (NYSE:ZTS)

Average Upside Potential: ~43.8%

Number of Hedge Fund Holders: 57

Zoetis Inc. (NYSE:ZTS) is one of the Best Wide Moat Stocks to Buy According to Wall Street Analysts. On May 18, Citi reduced its price objective on the company’s stock to $112 from $145 and kept a “Buy” rating on the shares. Notably, the firm reduced Zoetis Inc. (NYSE:ZTS)’s estimates after the difficult report for Q1 2026. However, the analyst believes that the company has a premium portfolio when the consumers are trading downwards.

The company saw revenue of $2.3 billion in Q1 2026, implying an increase of 3% YoY and flat on an organic operational basis. The revenue in the U.S. segment amounted to $1.1 billion, demonstrating a decline of 8% on a reported and organic operational basis compared to Q1 2025, with companion animal product sales falling 11% because of softer end-market demand and competitive landscape.

For FY 2026, Zoetis Inc. (NYSE:ZTS) expects revenue of between $9.680 billion – $9.960 billion (organic operational growth of 2% – 5%), while adjusted net income is anticipated between $2.870 billion and $2.950 billion (organic operational growth of 2% – 6%).

Zoetis Inc. (NYSE:ZTS) is a leading animal health company, and it discovers, develops, manufactures, and commercializes vaccines, medicines, diagnostics, biopharmaceuticals, and digital solutions for companion animals and livestock.